Protection against ventricular fibrillation via cholinergic receptor stimulation and the generation of nitric oxide

Journal of Physiology

Volumn 594, Issue 14, 2016, Pages 3981-3992

  Kalla, Manish ^a   Chotalia, Minesh ^a   Coughlan, Charles ^a   Hao, Guoliang ^a   Crabtree, Mark J ^a   Tomek, Jakub ^a   Bub, Gil ^a   Paterson, David J ^a   Herring, Neil ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBACHOL; CHOLINERGIC RECEPTOR; GUANYLATE CYCLASE; MUSCARINIC RECEPTOR; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE;

ANIMAL TISSUE; ANTIARRHYTHMIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; HEART MUSCLE POTENTIAL; HEART PROTECTION; HEART RATE; HEART VENTRICLE FIBRILLATION; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION;

EID: 84978828551     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/JP271588     Document Type: Article

References (70)

1. Akar FG & Rosenbaum DS (2003). Transmural electrophysiological heterogeneities underlying arrhythmogenesis in heart failure. Circ Res 93, 638–645.
2. Akar FG, Spragg DD, Tunin RS, Kass DA & Tomaselli GF (2004). Mechanisms underlying conduction slowing and arrhythmogenesis in nonischemic dilated cardiomyopathy. Circ Res 95, 717–725.
3. Ando M, Katare RG, Kakinuma Y, Zhang D, Yamasaki F, Muramoto K & Sato T (2005). Efferent vagal nerve stimulation protects heart against ischemia-induced arrhythmias by preserving connexin43 protein. Circulation 112, 164–170.
4. Ardell JL, Rajendran PS, Nier HA, KenKnight BH & Armour JA (2015). Central–peripheral neural network interactions evoked by vagus nerve stimulation: functional consequences on control of cardiac function. Am J Physiol Heart Circ Physiol 309, H1740–H1752.
5. Balligand JL, Kobzik L, Han X, Kaye DM, Belhassen L, O'Hara DS, Kelly RA, Smith TW & Michel T (1995). Nitric oxide-dependent parasympathetic signaling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytes. J Biol Chem 270, 14582–14586.
6. 2+ in rat intracardiac ganglion neurons. J Neurophysiol 90, 1956–1964.
7. Berthoud HR & Neuhuber WL (2000). Functional and chemical anatomy of the afferent vagal system. Auton Neurosci 85, 1–17.
8. Bishop MJ, Burton RA, Kalla M, Nanthakumar K, Plank G, Bub G & Vigmond EJ (2014). Mechanism of reentry induction by a 9-V battery in rabbit ventricles. Am J Physiol Heart Circ Physiol 306, H1041–H1053.
9. Brack KE, Coote JH & Ng GA (2011). Vagus nerve stimulation protects against ventricular fibrillation independent of muscarinic receptor activation. Cardiovasc Res 91, 437–446.
10. Brack KE, Narang R, Winter J & Ng GA (2013). The mechanical uncoupler blebbistatin is associated with significant electrophysiological effects in the isolated rabbit heart. Exp Physiol 98, 1009–1027.
11. Brack KE, Patel VH, Coote JH & Ng GA (2007). Nitric oxide mediates the vagal protective effect on ventricular fibrillation via effects on action potential duration restitution in the rabbit heart. J Physiol 583, 695–704.
12. Brack KE, Patel VH, Mantravardi R, Coote JH & Ng GA (2009). Direct evidence of nitric oxide release from neuronal nitric oxide synthase activation in the left ventricle as a result of cervical vagus nerve stimulation. J Physiol 587, 3045–3054.
13. Casadei B (2006). The emerging role of neuronal nitric oxide synthase in the regulation of myocardial function. Exp Physiol 91, 943–955.
14. Choi BR & Salama G (2000). Simultaneous maps of optical action potentials and calcium transients in guinea-pig hearts: mechanisms underlying concordant alternans. J Physiol 529, 171–188.
15. Coote JH (2013). Myths and realities of the cardiac vagus. J Physiol 591, 4073–4085.
16. Corr PB & Gillis RA (1974). Role of the vagus nerves in the cardiovascular changes induced by coronary occlusion. Circulation 49, 86–97.
17. Dawson TA, Li D, Woodward T, Barber Z, Wang L & Paterson DJ (2008). Cardiac cholinergic NO-cGMP signaling following acute myocardial infarction and nNOS gene transfer. Am J Physiol Heart Circ Physiol 295, H990–H998.
18. De Ferrari GM, Crijns HJ, Borggrefe M, Milasinovic G, Smid J, Zabel M, Gavazzi A, Sanzo A, Dennert R, Kuschyk J, Raspopovic S, Klein H, Swedberg K, Schwartz PJ & CardioFit Multicenter Trial Investigators (2011). Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure. Eur Heart J 32, 847–855.
19. De Ferrari GM, Salvati P, Grossoni M, Ukmar G, Vaga L, Patrono C & Schwartz PJ (1993). Pharmacologic modulation of the autonomic nervous system in the prevention of sudden cardiac death. A study with propranolol, methacholine and oxotremorine in conscious dogs with a healed myocardial infarction. J Am Coll Cardiol 22, 283–290.
20. De Ferrari GM, Vanoli E, Curcuruto P, Tommasini G & Schwartz PJ (1992). Prevention of life-threatening arrhythmias by pharmacologic stimulation of the muscarinic receptors with oxotremorine. Am Heart J 124, 883–890.
21. De Ferrari GM, Vanoli E, Stramba-Badiale M, Hull SS, Jr, Foreman RD & Schwartz PJ (1991). Vagal reflexes and survival during acute myocardial ischemia in conscious dogs with healed myocardial infarction. Am J Physiol 261, H63–H69.
22. Efimov IR, Nikolski VP & Salama G (2004). Optical imaging of the heart. Circ Res 95, 21–33.
23. Eglen RM, Michel AD, Cornett CM, Kunysz EA & Whiting RL (1989). The interaction of hexamethonium with muscarinic receptor subtypes in vitro. Br J Pharmacol 98, 499–506.
24. Einbrodt PP (1859). Ueber HerzreizungundihrVerhaeltniszum Blutdruck. Akademie der Wissenschaften (Vienna). Sitzungsberichte 38, 345.
25. Fedorov VV, Lozinsky IT, Sosunov EA, Anyukhovsky EP, Rosen MR, Balke CW & Efimov IR (2007). Application of blebbistatin as an excitation–contraction uncoupler for electrophysiologic study of rat and rabbit hearts. Heart Rhythm 4, 619–626.
26. Furchgott RF (1996). The 1996 Albert Lasker Medical Research Awards. The discovery of endothelium-derived relaxing factor and its importance in the identification of nitric oxide. JAMA 276, 1186–1188.
27. 2+ current in adult rabbit atrioventricular nodal cells. Circ Res 78, 998–1008.
28. Han X, Kubota I, Feron O, Opel DJ, Arstall MA, Zhao YY, Huang P, Fishman MC, Michel T & Kelly RA (1998). Muscarinic cholinergic regulation of cardiac myocyte ICa-L is absent in mice with targeted disruption of endothelial nitric oxide synthase. Proc Natl Acad Sci USA 95, 6510–6515.
29. Herring N, Golding S & Paterson DJ (2000). Pre-synaptic NO-cGMP pathway modulates vagal control of heart rate in isolated adult guinea pig atria. J Mol Cell Cardiol 32, 1795–1804.
30. Herring N & Paterson DJ (2001). Nitric oxide-cGMP pathway facilitates acetylcholine release and bradycardia during vagal nerve stimulation in the guinea-pig in vitro. J Physiol 535, 507–518.
31. Herron TJ, Lee P & Jalife J (2012). Optical imaging of voltage and calcium in cardiac cells & tissues. Circ Res 110, 609–623.
32. Ito M & Zipes DP (1994). Efferent sympathetic and vagal innervation of the canine right ventricle. Circulation 90, 1459–1468.
33. Kent KM, Smith ER, Redwood DR & Epstein SE (1973). Electrical stability of acutely ischemic myocardium. Influences of heart rate and vagal stimulation. Circulation 47, 291–298.
34. Kolman BS, Verrier RL & Lown B (1975). The effect of vagus nerve stimulation upon vulnerability of the canine ventricle: role of sympathetic-parasympathetic interactions. Circulation 52, 578–585.
35. Kostin S, Dammer S, Hein S, Klovekorn WP, Bauer EP & Schaper J (2004). Connexin 43 expression and distribution in compensated and decompensated cardiac hypertrophy in patients with aortic stenosis. Cardiovasc Res 62, 426–436.
36. La Rovere MT, Bigger JT, Jr, Marcus FI, Mortara A & Schwartz PJ (1998). Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet 351, 478–484.
37. Levy MN (1971). Sympathetic-parasympathetic interactions in the heart. Circ Res 29, 437–445.
38. Levy MN & Blattberg B (1976). Effect of vagal stimulation on the overflow of norepinephrine into the coronary sinus during cardiac sympathetic nerve stimulation in the dog. Circ Res 38, 81–84.
39. Levy MN & Zieske H (1969). Effect of enhanced contractility on the left ventricular response to vagus nerve stimulation in dogs. Circ Res 24, 303–311.
40. Lewis ME, Al-Khalidi AH, Bonser RS, Clutton-Brock T, Morton D, Paterson D, Townend JN & Coote JH (2001). Vagus nerve stimulation decreases left ventricular contractility in vivo in the human and pig heart. J Physiol 534, 547–552.
41. Maltsev VA, Sabbah HN, Higgins RS, Silverman N, Lesch M & Undrovinas AI (1998). Novel, ultraslow inactivating sodium current in human ventricular cardiomyocytes. Circulation 98, 2545–2552.
42. Martin PJ, Levy MN & Zieske H (1969). Analysis and simulation of the left ventricular response to autonomic nervous activity. Cardiovasc Res 3, 396–410.
43. Martin SR, Emanuel K, Sears CE, Zhang YH & Casadei B (2006). Are myocardial eNOS and nNOS involved in the beta-adrenergic and muscarinic regulation of inotropy? A systematic investigation. Cardiovasc Res 70, 97–106.
44. Martins JB & Zipes DP (1980a). Effects of sympathetic and vagal nerves on recovery properties of the endocardium and epicardium of the canine left ventricle. Circ Res 46, 100–110.
45. Martins JB & Zipes DP (1980b). Epicardial phenol interrupts refractory period responses to sympathetic but not vagal stimulation in canine left ventricular epicardium and endocardium. Circ Res 47, 33–40.
46. Mohan RM, Heaton DA, Danson EJ, Krishnan SP, Cai S, Channon KM & Paterson DJ (2002). Neuronal nitric oxide synthase gene transfer promotes cardiac vagal gain of function. Circ Res 91, 1089–1091.
47. f. Circ Res 81, 60–68.
48. Nash MP, Thornton JM, Sears CE, Varghese A, O'Neill M & Paterson DJ (2001). Ventricular activation during sympathetic imbalance and its computational reconstruction. J Appl Physiol (1985) 90, 287–298.
49. Ng GA, Brack KE & Coote JH (2001). Effects of direct sympathetic and vagus nerve stimulation on the physiology of the whole heart – a novel model of isolated Langendorff perfused rabbit heart with intact dual autonomic innervation. Exp Physiol 86, 319–329.
50. Nolan J, Batin PD, Andrews R, Lindsay SJ, Brooksby P, Mullen M, Baig W, Flapan AD, Cowley A, Prescott RJ, Neilson JM & Fox KA (1998). Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). Circulation 98, 1510–1516.
51. Palmer RM, Ferrige AG & Moncada S (1987). Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327, 524–526.
52. Pinder AG, Rogers SC, Khalatbari A, Ingram TE & James PE (2008). The measurement of nitric oxide and its metabolites in biological samples by ozone-based chemiluminescence. Methods Mol Biol 476, 11–28.
53. Pogwizd SM, McKenzie JP & Cain ME (1998). Mechanisms underlying spontaneous and induced ventricular arrhythmias in patients with idiopathic dilated cardiomyopathy. Circulation 98, 2404–2414.
54. Pogwizd SM, Schlotthauer K, Li L, Yuan W & Bers DM (2001). Arrhythmogenesis and contractile dysfunction in heart failure: roles of sodium–calcium exchange, inward rectifier potassium current, and residual beta-adrenergic responsiveness. Circ Res 88, 1159–1167.
55. Sabbah HN (2011). Electrical vagus nerve stimulation for the treatment of chronic heart failure. Cleve Clin J Med 78 Suppl 1, S24–S29.
56. Schwartz PJ, De Ferrari GM, Sanzo A, Landolina M, Rordorf R, Raineri C, Campana C, Revera M, Ajmone-Marsan N, Tavazzi L & Odero A (2008). Long term vagal stimulation in patients with advanced heart failure: first experience in man. Eur J Heart Fail 10, 884–891.
57. Shen MJ & Zipes DP (2014). Role of the autonomic nervous system in modulating cardiac arrhythmias. Circ Res 114, 1004–1021.
58. Shinlapawittayatorn K, Chinda K, Palee S, Surinkaew S, Kumfu S, Kumphune S, Chattipakorn S, KenKnight BH & Chattipakorn N (2014). Vagus nerve stimulation initiated late during ischemia, but not reperfusion, exerts cardioprotection via amelioration of cardiac mitochondrial dysfunction. Heart Rhythm 11, 2278–2287.
59. 2+ window current. Circ Res 70, 456–464.
60. Smit MJ & Iyengar R (1998). Mammalian adenylyl cyclases. Adv Second Messenger Phosphoprotein Res 32, 1–21.
61. Sunahara RK, Dessauer CW & Gilman AG (1996). Complexity and diversity of mammalian adenylyl cyclases. Annu Rev Pharmacol Toxicol 36, 461–480.
62. 2+ current in human atrial myocytes. J Physiol 506, 653–663.
63. Vandecasteele G, Eschenhagen T, Scholz H, Stein B, Verde I & Fischmeister R (1999). Muscarinic and beta-adrenergic regulation of heart rate, force of contraction and calcium current is preserved in mice lacking endothelial nitric oxide synthase. Nat Med 5, 331–334.
64. Vanoli E, De Ferrari GM, Stramba-Badiale M, Hull SS, Jr, Foreman RD & Schwartz PJ (1991). Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction. Circ Res 68, 1471–1481.
65. Wang L, Li D, Dawson TA & Paterson DJ (2009). Long-term effect of neuronal nitric oxide synthase over-expression on cardiac neurotransmission mediated by a lentiviral vector. J Physiol 587, 3629–3637.
66. Wickenden AD, Kaprielian R, Kassiri Z, Tsoporis JN, Tsushima R, Fishman GI & Backx PH (1998). The role of action potential prolongation and altered intracellular calcium handling in the pathogenesis of heart failure. Cardiovasc Res 37, 312–323.
67. Xu KY, Huso DL, Dawson TM, Bredt DS & Becker LC (1999). Nitric oxide synthase in cardiac sarcoplasmic reticulum. Proc Natl Acad Sci USA 96, 657–62.
68. Yan GX, Rials SJ, Wu Y, Liu T, Xu X, Marinchak RA & Kowey PR (2001). Ventricular hypertrophy amplifies transmural repolarization dispersion and induces early afterdepolarization. Am J Physiol Heart Circ Physiol 281, H1968–H1975.
69. Yoon MS, Han J, Tse WW & Rogers R (1977). Effects of vagal stimulation, atropine, and propranolol on fibrillation threshold of normal and ischemic ventricles. Am Heart J 93, 60–65.
70. Zeng J & Rudy Y (1995). Early afterdepolarizations in cardiac myocytes: mechanism and rate dependence. Biophys J 68, 949–964.